Avonex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

Elan hit by 'disaster' withdrawal

Both patients were involved in a trial that examined the effectiveness of Tysabri in combination with Biogen's existing MS drug, Avonex, on the market for nearly nine years.

Analysts back Tysabri return despite FDA concern

Tysabri was withdrawn a year ago after two patients taking it in combination with another Biogen MS drug, Avonex, developed a rare and often fatal brain infection known as progressive multifocal

Lectus wins USD 6.1m investment from Wellcome Trust

It is the fifth largest segment of the CNS market. The MS market is currently dominated by six treatments: Avonex (Biogen), Betaseron/Betaferon (Schering), Copaxone (Teva), Novatrone (Schering), Rebif (Serono/ Pfizer)

New accounts: May

Grandma Vines. Dermatology (consumer). hsdcommunications. Biogen Idec. Avonex. CNS. TVF Communications.

PM Society Award Winners 2006

Craft Award:Detailing Aid. Winner:Seven Stones for Avonex. Sponsor: Ashfield Healthcare. Craft Award:GP Direct Mail Campaign. ... Sponsor:Wiley Pharmafile. Craft Award:Hospital Campaign. Winner:Seven Stones for Avonex. Sponsor: TNS Healthcare.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology